相关实验视频
Updated: Jan 18, 2026

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
41.2K
喘中的乌比奎丁-蛋白酶系统:机制和治疗可能性
Shuangyu He1, Siqi Wen1, Zhen Wang2
1Department of Pediatrics, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, Liaoning Province, 110000, China.
Clinical reviews in allergy & immunology
|September 11, 2025
概括
无素蛋白酶体系统 (UPS) 在喘中至关重要,调节关键过程. 本综述详细介绍了UPS组件,遗传联系和喘管理的治疗目标.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 无素-蛋白酶体系统 (UPS) 通过翻译后修改来调节蛋白质的稳定性和活性.
- UPS功能障碍与喘的发病有关.
研究的目的:
- 在喘中全面分析UPS组件.
- 研究UPS在喘病理学,遗传学和治疗向中的作用.
主要方法:
- 对42个UPS组件 (E2,E3结合酶,DUB,蛋白酶) 的系统审查.
- 对UPS参与气道炎症,高反应性,粘液高分泌和重塑的分析.
- 对UPS基因多态和喘易感性进行文献综述和GWAS数据分析.
主要成果:
- 确定了25个E3酶基质和7个涉及喘的DUB基质对.
- 在9个与喘相关的UPS基因中发现了20个单核酸多态 (SNP).
- 突出显示了24种可用药的UPS目标和24种相关化合物,其中10种与喘相关.
结论:
- 通过各种机制,UPS在喘发病过程中发挥着重要作用.
- UPS组件及其遗传变异代表了喘的潜在治疗标.
- 像PROTAC和纳米疫苗这样的新兴策略为喘提供了新的治疗途径.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Antiasthma Drugs: Leukotriene Modifiers
1.8K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.8K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K

